GPX4 and hepatocellular carcinoma: Taken together, these results suggested that ExoSP94-Lamp2b-RRM-multi-siRNA#1 could enhance sorafenib-induced ferroptosis in HCC cells by silencing the expression of GPX4 and DHODH.